Siemens Healthineers has announced the launch of a new range of human papillomavirus (HPV) tests, designed to aid the detection of high-risk strains.
Created by its subsidiary Fast Track Diagnostics, the new real-time polymerase chain reaction (PCR) and reverse transcription PCR kits amplify DNA and RNA from laboratory samples, allowing clinicians to diagnose infections rapidly.
“Siemens Healthineers has launched a new real-time PCR kit for the detection of 14 HPV high-risk subtypes.“
It can be used to detect HPV 16, HPV 18 and a pool of 12 other high-risk subtypes, including an endogenous control. These subtypes are responsible for nearly all cervical cancers, with HPV type 16 and 18 accounting for over 70 percent of cases between them.
The new assay is based on multiplex real-time PCR technology, and has now received CE Mark approval for sale in Europe.
Fernando Beils, head of molecular diagnostics at Siemens Healthineers, said: "This new assay provides a new precision medicine solution that can enable clinicians to better diagnose and treat these high-risk strains of HPV."
With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Science